Abstract
Classic chemotherapy has little or no specificity for cancer cells, normally resulting in low accumulation at the tumor region (inefficacy), and in severe side effects (toxicity). This challenge has resulted in the development of several delivery strategies for chemotherapy agents to improve their concentration at the tumor site, simultaneously increasing their anticancer efficacy, while reducing the associated adverse systemic effects. In this work, the potential of drug delivery strategies involving the use of nanocarriers for controlling the biodistribution of antitumor drugs is deeply revised: passive targeting (through the enhanced permeability and retention effect, EPR effect) and active targeting (including stimuli-sensitive carriers and ligand-mediated delivery). Special attention will be also focussed on the recent approaches for overcoming multi-drug resistance. Finally, a general view of the problem of “nanotoxicity” in cancer treatment is also given.
Keywords: Active targeting, antitumor activity, cancer treatment, chemotherapy agent, colloidal drug delivery systems, controlled release, drug carrier, nanotoxicity, passive targeting, 5-fluorouracil, multi-drug resistance, reticuloendothelial system, mononuclear phagocyte system, opsonins, Doxorubicin, DOX-SLNs, caprolactone, tamoxifen, PLA-PEG, asialoglycoprotein, HepG2, monoclonal antibodies, Pseudomonas, PE38KDEL, Flow cytometry, confocal microscopy, Peptide-Mediated Targeting, Inulin multi-methacrylate (IMMA), CREKA, fibronectin, DAOY, vasoactive intestinal peptide, Integrin-Mediated Targeting, H2009, Aptamer-Mediated Targeting, PSMA, LNCaP xenograft, Folate Receptor Targeting, HeLa, paclitaxel prodrug, Cremophor, prodrug therapy, TRAIL immunotherapy, Transferrin Receptor Targeting, fluorescence microscopic, EGFR, acute myeloid leukemia, hyperthermia, Thermo-sensitive magnetoliposomes, methotrexate, Magnetic Drug Targeting, Ultrasound-Mediated Drug Delivery, Low frequency ultrasound, metalloproteinase-2, PEGylation, paclitaxel, tariquidar, Myocet, Doxil, Caelyx, Genexol-PM
Mini-Reviews in Medicinal Chemistry
Title: Drug Targeting Strategies in Cancer Treatment: An Overview
Volume: 11 Issue: 1
Author(s): J. L. Arias
Affiliation:
Keywords: Active targeting, antitumor activity, cancer treatment, chemotherapy agent, colloidal drug delivery systems, controlled release, drug carrier, nanotoxicity, passive targeting, 5-fluorouracil, multi-drug resistance, reticuloendothelial system, mononuclear phagocyte system, opsonins, Doxorubicin, DOX-SLNs, caprolactone, tamoxifen, PLA-PEG, asialoglycoprotein, HepG2, monoclonal antibodies, Pseudomonas, PE38KDEL, Flow cytometry, confocal microscopy, Peptide-Mediated Targeting, Inulin multi-methacrylate (IMMA), CREKA, fibronectin, DAOY, vasoactive intestinal peptide, Integrin-Mediated Targeting, H2009, Aptamer-Mediated Targeting, PSMA, LNCaP xenograft, Folate Receptor Targeting, HeLa, paclitaxel prodrug, Cremophor, prodrug therapy, TRAIL immunotherapy, Transferrin Receptor Targeting, fluorescence microscopic, EGFR, acute myeloid leukemia, hyperthermia, Thermo-sensitive magnetoliposomes, methotrexate, Magnetic Drug Targeting, Ultrasound-Mediated Drug Delivery, Low frequency ultrasound, metalloproteinase-2, PEGylation, paclitaxel, tariquidar, Myocet, Doxil, Caelyx, Genexol-PM
Abstract: Classic chemotherapy has little or no specificity for cancer cells, normally resulting in low accumulation at the tumor region (inefficacy), and in severe side effects (toxicity). This challenge has resulted in the development of several delivery strategies for chemotherapy agents to improve their concentration at the tumor site, simultaneously increasing their anticancer efficacy, while reducing the associated adverse systemic effects. In this work, the potential of drug delivery strategies involving the use of nanocarriers for controlling the biodistribution of antitumor drugs is deeply revised: passive targeting (through the enhanced permeability and retention effect, EPR effect) and active targeting (including stimuli-sensitive carriers and ligand-mediated delivery). Special attention will be also focussed on the recent approaches for overcoming multi-drug resistance. Finally, a general view of the problem of “nanotoxicity” in cancer treatment is also given.
Export Options
About this article
Cite this article as:
L. Arias J., Drug Targeting Strategies in Cancer Treatment: An Overview, Mini-Reviews in Medicinal Chemistry 2011; 11 (1) . https://dx.doi.org/10.2174/138955711793564024
DOI https://dx.doi.org/10.2174/138955711793564024 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
Call for Papers in Thematic Issues
Bioprospecting of Natural Products as Sources of New Multitarget Therapies
According to the Convention on Biological Diversity, bioprospecting is the exploration of biodiversity and indigenous knowledge to develop commercially valuable products for pharmaceutical and other applications. Bioprospecting involves searching for useful organic compounds in plants, fungi, marine organisms, and microorganisms. Natural products traditionally constituted the primary source of more than ...read more
Computational Frontiers in Medicinal Chemistry
The thematic issue "Computational Frontiers in Medicinal Chemistry" provides a robust platform for delving into state-of-the-art computational methodologies and technologies that significantly propel advancements in medicinal chemistry. This edition seeks to amalgamate top-tier reviews spotlighting the latest trends and breakthroughs in the fusion of computational approaches, including artificial intelligence (AI) ...read more
Natural Products and Dietary Supplements in Alleviation of Metabolic, Cardiovascular, and Neurological Disorders
Metabolic disorders like diabetes, obesity, inflammation, oxidative stress, cancer etc, cardiovascular disorders like angina, myocardial infarction, congestive heart failure etc as well as neurological disorders like Alzheimer?s, Parkinson?s, Epilepsy, Depression, etc are the global burden. They covered the major segment of the diseases and disorders from which the human community ...read more
Natural Products in Drug Discovery
Natural products have always been one of the important ways of drug discovery due to their novel skeleton and diverse functional group characteristics. According to statistics, between 1981 and 2019, the FDA approved a total of 1,394 small molecule drugs for marketing, of which 930 marketed drugs originated from the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Emerging Multi-cancer Regulatory Role of ESRP1: Orchestration of Alternative Splicing to Control EMT
Current Cancer Drug Targets Part I: Targeted Particles for Cancer Immunotherapy
Current Drug Delivery Radioactive Nanoparticles and their Main Applications: Recent Advances
Recent Patents on Nanotechnology Secretory Leukocyte Protease Inhibitor: More than Just A Protease Inhibitor
Current Immunology Reviews (Discontinued) A Systematic Review of Genes Involved in the Inverse Resistance Relationship Between Cisplatin and Paclitaxel Chemotherapy: Role of BRCA1
Current Cancer Drug Targets Synthesis and in vitro Evaluation of the Anticancer Potential of New Aminoalkanol Derivatives of Xanthone
Anti-Cancer Agents in Medicinal Chemistry Alpha-Interferon and Its Effects on Signalling Pathways Within Cells
Current Protein & Peptide Science Prediction of Cancer Rescue p53 Mutants In Silico Using Naïve Bayes Learning Methodology
Protein & Peptide Letters Current Evidence and Potential Mechanisms of Therapeutic Action of PEDF in Cervical Cancer Treatment
Current Molecular Medicine Inhibition of Hedgehog/Gli Signaling by Botanicals: A Review of Compounds with Potential Hedgehog Pathway Inhibitory Activities
Current Cancer Drug Targets Acute Toxicological and Histopathological Elucidation of <i>Rheum emodi</i> Rhizome Extract to Demonstrate Antidiabetic Activity in Alloxan-induced Diabetic Rats
Current Bioactive Compounds Antitumor Activity of Zinc Nanoparticles Synthesized with Berberine on Human Epithelial Colorectal Adenocarcinoma (Caco-2) Cells through Acting on Cox-2/NF-kB and p53 Pathways
Anti-Cancer Agents in Medicinal Chemistry Antioxidant, Pro-Oxidant and Other Biological Activities of Sesquiterpenes
Current Topics in Medicinal Chemistry Antioxidant Effect of Flavonoids Present in Euterpe oleracea Martius and Neurodegenerative Diseases: A Literature Review
Central Nervous System Agents in Medicinal Chemistry Medicinal Chemistry of Probimane and MST-16: Comparison of Anticancer Effects Between Bisdioxopiperazines
Medicinal Chemistry Universal Human Papillomavirus Vaccination and its Impact on the Southern Italian Region
Current Pharmaceutical Design Small-Molecule Inhibitors Targeting eIF4A in Leukemia
Current Protein & Peptide Science Reversal of Bone Cancer Pain by HSV-1-Mediated Silencing of CNTF in an Afferent Area of the Spinal Cord Associated with AKT-ERK Signal Inhibition
Current Gene Therapy The Role of NF-κB Inhibitors in Cell Response to Radiation
Current Medicinal Chemistry The Potential Role of Pharmacogenomic and Genomic in the Adjuvant Treatment of Early Stage Non Small Cell Lung Cancer
Current Genomics